ABT | Abbott Laboratories

Today
2.28
%
$
107.39
Beginners
Defensive

About Abbott

Abbott is an American healthcare company that designs and sells medical devices, products for diagnostics, and nutrition. Learn the latest information and analysis on the company, ABT stock price today, stock news, how much one share costs and other information to help you make investment decisions. 

Check out Gainy to see insights on stock prices and more.

Abbott was founded by Dr. Wallace C. Abbott, a practicing physician that owned a drug store and created a new approach to extracting the active part of medicinal plants. Abbott opened an affiliate in London in 1907 and later opened one in Montreal, Canada. Abbott India was established in 1944 and remains an important subsidiary and the country’s largest healthcare products company.

Abbott has a quality business with a capital allocation that’s friendly to shareholders and pays stable and consistent dividends. The company’s strong balance sheet makes the stock a great pick in times of uncertainty.

The Abbott stock price of around $100 may be a good entry point for a relatively safe investment, which may be able to bring up to 40% returns in the next 12 months.

Check back to this page for the ABT stock quote or download Gainy to see if ABT fits your portfolio and investment goals, as well as other stock quotes and recommendations that fit your portfolio and interests.

Market Data

Market
Capitalization
$
183.08B
30 days price change
8.73
%
Revenue Growth
Quarterly, YoY
-4.70
%
Volume, Today
4.62M
EV/S
4.29
%
Net Profit Margin
TTM, ANNUAL
17.52%

Ratings

4.08
bullish
Very bullish
Neutral
Bearish
Very Bearish
Very bullish
6
Bullish
5
Neutral
1
Bearish
1
Very Bearish
3
Price Target
$
116.38
Does it work for you
More information in Gainy App
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Download on the App Store
Try thematic trading fractional collections! They’re thematic, diversified, built for long-term returns, and they’re right here in our brand new web platform.
Try it now